Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration

International Journal of Pharmaceutical Compounding

Volumn 11, Issue 1, 2007, Pages 82-85

  Trusley, Craig ^a   Ben, Michel ^a   Kupiec, Thomas C ^a   Trissel, Lawrence A ^b  

^a Analytical Research Laboratories   (United States)

^b TriPharma Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE; PALONOSETRON; PROMETHAZINE;

ARTICLE; DILUTION; DRUG SCREENING; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIMULATION; TURBIDITY;

EID: 33847272052     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aloxi [palonosetron hydrochloride injection prescribing information]. Bloomington, MN: MGI PHARMA, Inc., January 2006.
2. Gralla R, Lichinitser M, Van Der Vegt S et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: Results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003; 14(10): 1570-1577.
3. 3 receptor antagonist: Results of a phase III, single-dose trial versus dolasetron. Cancer 2003; 98(11): 2473-2482.
4. Aapro MS, Grunberg SM, Manikhas GM et al. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 2006; 17(9): 1441-1449.
5. Xu QA, Trissel LA. Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration. Am J Health Syst Pharm 2004; 61(15): 1596-1598.
6. Trissel LA, Zhang Y. Compatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate. IJPC 2004; 8(5): 398-403.
7. Trissel LA, Xu QA. Physical and chemical stability of palonosetron HCl in 4 infusion solutions. Ann Pharmacother 2004; 38(10): 1608-1611.
8. Trissel LA, Zhang YP. Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin, and oxaliplatin during simulated Y-site administration. J Onc Pharm Pract 2004; 10(4): 191-195.
9. Trissel LA, Zhang Y. Palonosetron hydrochloride compatibility and stability with doxorubicin hydrochloride and epirubicin hydrochloride during simulated Y-site administration. Ann Pharmacother 2005; 39: 280-283.
10. Trissel LA, Xu QA. Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration. IJPC 2005; 9(3): 238-241.
11. Trissel LA, Xu QA. Physical and chemical compatibility of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administration. IJPC 2005; 9(3): 235-237.
12. Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. IJPC 2005; 9(4): 320-322.
13. Xu QA, Trissel LA. Compatibility of palonosetron hydrochloride with cyclophosphamide and with ifosfamide during simulated Y-site administration. Am J Health Syst Pharm 2005; 62(19): 1998-2000.
14. Trissel LA, Zhang Y, Xu QA. Physical and chemical stability of palonosetron hydrochloride with dacarbazine and methylprednisolone sodium succinate during simulated Y-site administration. IJPC 2006; 10(3): 234-236.
15. Trissel LA, Trusley C, Ben M et al. Physical and chemical stability of palonosetron hydrochloride with five narcotics during simulated Y-site administration. Am J Health Syst Pharm [In press].
16. Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm 1977; 34(9): 939-943.
17. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm 1992; 49(7):1716-1719.
18. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993; 50(2): 300-304.
19. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993; 50(11): 2359-2363.
20. Palonosetron HCl IV Injection 0.05 mg/mL and 0.15 mg/mL end product test procedure. Minneapolis, MN: MGI PHARMA, Inc.; [Undated].
21. Fatmi AA, Williams GV Sr. Analysis of metoclopramide and related compounds in tablets by liquid chromatography. Drug Dev Ind Pharm 1989; 15: 1365-1373.
22. United States Pharmacopeia, Inc. United States Pharmacopeia 28-National Formulary 23. Rockville, MD: United States Pharmacopeial Convention, Inc.; 2005: 1641-1642.